Refresh
Company Event • 02 Nov 2021 09:30 • Latest
Location:Japan
Fiscal 2021 2Q Financial Results Briefing
Speakers
- Isao Teshirogi (President & CEO, SHIONOGI & CO., LTD.)
- Takuko Sawada (Director and Executive Vice President and Senior Vice President, Integrated Disease Care Department, SHIONOGI & CO., LTD.)
- John Keller (Senior Executive Officer, Senior Vice President, Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yuji Hosogai (Vice President, Finance & Accounting Department Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yoshimasa Kyokawa (Vice President, Corporate Communications Department and Corporate Secretariat, Corporate Strategy Division, SHIONOGI & CO., LTD.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
- Naomi Kumagai (Analyst, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Hyogo (Analyst, Mitsubishi UFJ Trust and Banking Corporation)
Company Event • 29 Sep 2021 09:00
Location:1-5-1 Marunouchi
Chiyoda-ku
Japan
R&D Briefing
Speakers
- Isao Teshirogi (President & CEO, SHIONOGI & CO., LTD.)
- Takuko Sawada (Director and Executive Vice President and Senior Vice President, Integrated Disease Care Department, SHIONOGI & CO., LTD.)
- Toshinobu Iwasaki (Senior Executive Officer, Senior Vice President, Global Development Division, SHIONOGI & CO., LTD.)
- Ryuichi Kiyama Ph.D. (Senior Executive Officer, Senior Vice President, Pharmaceutical Research Division, SHIONOGI & CO., LTD.)
- Yasuyoshi Isou Ph.D. (Corporate Officer, Senior Vice President, CMC Research Division, SHIONOGI & CO., LTD.)
- Yoshimasa Kyokawa (Vice President, Corporate Communications Department and Corporate Secretariat, Corporate Strategy Division, SHIONOGI & CO., LTD.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
- Naomi Kumagai (Analyst, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
Duration
- Presentation: 50 minutes
- Q&A: 50 minutes
Company Event • 02 Aug 2021 16:00
Location:Japan
Fiscal 2021 1Q Conference Call
Speakers
- Takuko Sawada (Director and Executive Vice President and Senior Vice President, Integrated Disease Care Department, SHIONOGI & CO., LTD.)
- John Keller (Senior Executive Officer, Senior Vice President, Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yuji Hosogai (Vice President, Finance & Accounting Department Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yoshimasa Kyokawa (Vice President, Corporate Communications Department and Corporate Secretariat, Corporate Strategy Division, SHIONOGI & CO., LTD.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
- Tatsuyuki Arai (Analyst, BofA Securities Japan Co., Ltd.)
- Hiroshi Tanaka (Analyst, Mizuho Securities Co., Ltd.)
Company Event • 11 May 2021 09:30
Location:Japan
Fiscal 2020 Financial Results Briefing
Speakers
- Isao Teshirogi (President & CEO, SHIONOGI & CO., LTD.)
- Takuko Sawada (Director and Executive Vice President and Senior Vice President, Integrated Disease Care Department, SHIONOGI & CO., LTD.)
- Koji Hanasaki (Senior Executive Officer, Senior Vice President, Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yuji Hosogai (Vice President, Finance & Accounting Department Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yoshimasa Kyokawa (Vice President, Corporate Communications Department and Corporate Secretariat, Corporate Strategy Division, SHIONOGI & CO., LTD.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
Company Event • 01 Feb 2021 14:00
Location:Japan
3rd Quarter of Fiscal 2020 Financial Results Conference Call
Speakers
- Takuko Sawada (Director and Executive Vice President and Senior Vice President of Integrated Disease Care Department, SHIONOGI & CO., LTD.)
- Koji Hanasaki (Senior Executive Officer, Senior Vice President, Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yuji Hosogai (Vice President, Finance & Accounting Department Corporate Strategy Division, SHIONOGI & CO., LTD.)
- Yoshimasa Kyokawa (Vice President, Corporate Communications Department and Corporate Secretariat, Corporate Strategy Division, SHIONOGI & CO., LTD.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)